S16I (p.Ser16Ile) variant of CDX2 (Homeobox protein CDX-2)
S16I (p.Ser16Ile) in CDX2 (Homeobox protein CDX-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions.
S16I (p.Ser16Ile) variant details
- p.Ser16Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.13
- MetaSVM -0.96
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.